58 related articles for article (PubMed ID: 38436543)
1. MIF as a potential diagnostic and prognostic biomarker for triple-negative breast cancer that correlates with the polarization of M2 macrophages.
Chen M; Liu H; Hong B; Xiao Y; Qian Y
FASEB J; 2024 May; 38(10):e23696. PubMed ID: 38787620
[TBL] [Abstract][Full Text] [Related]
2. CT-Based Radiogenomics of P4HA3 Expression in Clear Cell Renal Cell Carcinoma.
Greco F; Panunzio A; Tafuri A; Bernetti C; Pagliarulo V; Zobel BB; Scardapane A; Mallio CA
Acad Radiol; 2024 Mar; 31(3):902-908. PubMed ID: 37537130
[TBL] [Abstract][Full Text] [Related]
3. RGC32 promotes the progression of ccRCC by activating the NF-κB/SHP2/EGFR signaling pathway.
Zhang J; Sun Y; Tang K; Xu H; Xiao J; Li Y
Aging (Albany NY); 2024 May; 16():. PubMed ID: 38809518
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma.
Parol-Kulczyk M; Durślewicz J; Blonkowska L; Wujec R; Gzil A; Piątkowska D; Ligmanowska J; Grzanka D
J Pathol Clin Res; 2024 Mar; 10(2):e12365. PubMed ID: 38436543
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Pasupuleti V; Du W; Gupta Y; Yeh IJ; Montano M; Magi-Galuzzi C; Welford SM
J Biol Chem; 2014 Feb; 289(6):3713-23. PubMed ID: 24356968
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Pei XJ; Wu TT; Li B; Tian XY; Li Z; Yang QX
Int J Med Sci; 2014; 11(1):106-15. PubMed ID: 24396292
[TBL] [Abstract][Full Text] [Related]
8. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
[TBL] [Abstract][Full Text] [Related]
9. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
10. Low Expression of MATR3 Is Associated with Poor Survival in Clear Cell Renal Cell Carcinoma.
Durślewicz J; Klimaszewska-Wiśniewska A; Antosik P; Grzanka D
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830863
[TBL] [Abstract][Full Text] [Related]
11. MIF/SCL3A2 depletion inhibits the proliferation and metastasis of colorectal cancer cells via the AKT/GSK-3β pathway and cell iron death.
Huang G; Ma L; Shen L; Lei Y; Guo L; Deng Y; Ding Y
J Cell Mol Med; 2022 Jun; 26(12):3410-3422. PubMed ID: 35567291
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of SDF-1 chemokine and its receptors CXCR4 and CXCR7 involved in EMT of prostate cancer.
Parol-Kulczyk M; Gzil A; Ligmanowska J; Grzanka D
Cytokine; 2022 Feb; 150():155778. PubMed ID: 34920230
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study.
Parol-Kulczyk M; Gzil A; Maciejewska J; Bodnar M; Grzanka D
PLoS One; 2021; 16(6):e0253112. PubMed ID: 34157052
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
